Astera Labs (NASDAQ:ALAB) General Counsel Philip Mazzara Sells 10,000 Shares

04 Apr 2026, 00:18 by Tristan Rich · The Markets Daily

Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the transaction, the general counsel directly owned 118,084 shares of the company’s stock, valued at approximately $12,725,912.68. This represents a 7.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Philip Mazzara also recently made the following trade(s):

On Monday, March 2nd, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $117.47, for a total transaction of $1,174,700.00.
On Tuesday, February 17th, Philip Mazzara sold 4,849 shares of Astera Labs stock. The stock was sold at an average price of $123.80, for a total transaction of $600,306.20.

Astera Labs Price Performance

NASDAQ ALAB remained flat at $117.14 during trading on Friday. 4,484,582 shares of the company’s stock traded hands, compared to its average volume of 4,566,307. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90. The firm’s 50 day moving average price is $132.61 and its 200 day moving average price is $160.43. The stock has a market cap of $20.06 billion, a PE ratio of 96.02, a price-to-earnings-growth ratio of 2.09 and a beta of 1.78.

Astera Labs (NASDAQ:ALAB – Get Free Report) last released its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter in the prior year, the firm posted $0.37 earnings per share. The company’s quarterly revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

Positive Sentiment: Citi initiated/maintained a Buy and set a $200 price target on ALAB, highlighting PCIe and AI-infrastructure opportunity — a sizable analyst endorsement that can lift sentiment and buying interest. Benzinga Coverage
Positive Sentiment: Research notes (TipRanks summary) underscore Astera Labs’ PCIe switch leadership and positioning in rack-scale AI connectivity, framing multiyear revenue upside tied to data-center AI buildouts. Astera Labs: Leveraging PCIe Switch Leadership…
Positive Sentiment: Astera appears on roundups of leading growth stocks with notable insider ownership — a signal some investors use to judge management alignment and conviction, which can support valuation multiple expansion if execution continues. April 2026’s Leading Growth Stocks With Insider Ownership
Neutral Sentiment: Company announced it will report Q1 2026 results after market close on May 5 and hold a conference call — an imminent catalyst that could swing the stock depending on revenue, margins and guidance. Astera Labs Announces Conference Call…
Negative Sentiment: Recent articles flag a ~36% YTD decline and call out margin pressure and intensifying competition as key near-term risks; these concerns help explain the share-price pullback despite top-line AI/PCIe tailwinds. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD?
Negative Sentiment: Analyst commentary and newsletter pieces emphasize margin compression risks even as demand grows — if margins miss or competition accelerates, upside expectations tied to AI/PCIe could be delayed. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD? (Zacks)

Institutional Investors Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently bought and sold shares of ALAB. Vanguard Group Inc. grew its position in shares of Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after buying an additional 84,365 shares in the last quarter. State Street Corp increased its stake in shares of Astera Labs by 32.5% during the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after buying an additional 760,358 shares during the period. Geode Capital Management LLC raised its holdings in shares of Astera Labs by 4.5% in the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after acquiring an additional 104,935 shares in the last quarter. Fred Alger Management LLC lifted its stake in Astera Labs by 25.5% in the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock worth $321,855,000 after acquiring an additional 393,250 shares during the period. Finally, Morgan Stanley lifted its stake in Astera Labs by 33.0% in the fourth quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock worth $321,818,000 after acquiring an additional 480,009 shares during the period. 60.47% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms have weighed in on ALAB. Barclays set a $165.00 target price on Astera Labs in a research note on Thursday, January 15th. Northland Securities upped their price target on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. Loop Capital initiated coverage on shares of Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target on the stock. Weiss Ratings lowered shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Finally, Royal Bank Of Canada initiated coverage on shares of Astera Labs in a research report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price objective for the company. Fifteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $199.44.

Get Our Latest Stock Report on Astera Labs

About Astera Labs

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.